Cargando…

Diverting epithelial-to-mesenchymal transition to transform cancer cells to adipocytes: A promising strategy to stop metastasis

Detalles Bibliográficos
Autores principales:	Dalamaga, Maria, Christodoulatos, Gerasimos S., Liu, Junli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424808/ https://www.ncbi.nlm.nih.gov/pubmed/32812919 http://dx.doi.org/10.1016/j.metop.2019.100012

Ejemplares similares

Sotagliflozin, a dual SGLT1 and SGLT2 inhibitor: In the heart of the problem
por: Vallianou, Natalia G., et al.
Publicado: (2021)

Understanding the Co-Epidemic of Obesity and COVID-19: Current Evidence, Comparison with Previous Epidemics, Mechanisms, and Preventive and Therapeutic Perspectives
por: Dalamaga, Maria, et al.
Publicado: (2021)

The Epithelial-to-Mesenchymal Transition in Cancer
por: Roche, Joëlle
Publicado: (2018)

Epithelial–mesenchymal transition in cancer
por: Moustakas, Aristidis, et al.
Publicado: (2017)

Epithelial–Mesenchymal Transition (EMT)
por: Manfioletti, Guidalberto, et al.
Publicado: (2023)

Anti-viral treatment for SARS-CoV-2 infection: A race against time amidst the ongoing pandemic
por: Vallianou, Natalia G., et al.
Publicado: (2021)

Mycobiome and Cancer: What Is the Evidence?
por: Vallianou, Natalia, et al.
Publicado: (2021)

Epithelial-Mesenchymal Transition and Metastasis under the Control of Transforming Growth Factor β
por: Tsubakihara, Yutaro, et al.
Publicado: (2018)

Mesenchymal-Epithelial Transition in Oral Cancer
por: Patil, Shankargouda, et al.
Publicado: (2015)

Epithelial–Mesenchymal Transition (EMT) 2021
por: Manfioletti, Guidalberto, et al.
Publicado: (2022)

Epithelial–mesenchymal transition in tumor metastasis
por: Yeung, Kay T., et al.
Publicado: (2016)

Metabolism Open: A new journal in the quest of the golden fleece in metabolic research
por: Dalamaga, Maria, et al.
Publicado: (2019)

Mitochondrial glycerol 3-phosphate dehydrogenase deficiency aggravates hepatic triglyceride accumulation and steatosis
por: Dalamaga, Maria, et al.
Publicado: (2019)

Targeting gasdermin D and neutrophil mobilization for cardioprotection
por: Dalamaga, Maria, et al.
Publicado: (2021)

Phase separation may drive mitochondrial nucleoid compartmentation
por: Dalamaga, Maria, et al.
Publicado: (2022)

A chromatin remodeling checkpoint of diet-induced macrophage activation in adipose tissue
por: Dalamaga, Maria, et al.
Publicado: (2022)

DRAK2-SRSF6-regulated RNA alternative splicing is a promising therapeutic target in NAFLD/NASH
por: Dalamaga, Maria, et al.
Publicado: (2021)

Gut mycobiome as a promising preventive and therapeutic target for metabolic disorders
por: Dalamaga, Maria, et al.
Publicado: (2022)

Sphingolipids modulate the epithelial–mesenchymal transition in cancer
por: Levade, T, et al.
Publicado: (2015)

Revisiting mTOR and Epithelial–Mesenchymal Transition
por: Herrerias, Mariana M., et al.
Publicado: (2020)

Epithelial-Mesenchymal Transition with Malignant Transformation Leading Multiple Metastasis from Disseminated Peritoneal Leiomyomatosis
por: Chiu, Hsiao-Chen, et al.
Publicado: (2018)

Lysyl Oxidase at the Crossroads of Mesenchymal Stem Cells and Epithelial-Mesenchymal Transition
por: Thomas, Clémence, et al.
Publicado: (2013)

Could hyperglycemia-induced cardiac autoimmunity be hidden behind cardiovascular disease in type 1 diabetes mellitus?
por: Vallianou, Natalia, et al.
Publicado: (2019)

What are the key points in the association between the gut microbiome and nonalcoholic fatty liver disease?
por: Vallianou, Natalia, et al.
Publicado: (2019)

The non-linear relationship between muscle mass and BMI calls into question the use of BMI as a major criterion for eligibility for bariatric surgery
por: Liu, Junli, et al.
Publicado: (2022)

Could gut mycobiome play a role in NAFLD pathogenesis? Insights and therapeutic perspectives
por: Fotis, Dimitrios, et al.
Publicado: (2022)

Targeting MRG15 for the treatment of nonalcoholic steatohepatitis
por: Zhang, Yao, et al.
Publicado: (2022)

Ubiquitin-specific protease 22 promotes lipogenesis contributing to Hepatocellular Carcinoma pathogenesis
por: Xu, Yanyan, et al.
Publicado: (2022)

Targeting epithelial-mesenchymal transition pathway in hepatocellular carcinoma
por: Song, Jaewhan
Publicado: (2020)

Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives
por: Vallianou, Natalia, et al.
Publicado: (2021)

SLPI: a new target for stopping metastasis
por: Munn, Lance L., et al.
Publicado: (2018)

Could exercise hormone irisin be a therapeutic agent against Parkinson’s and other neurodegenerative diseases?
por: Avgerinos, Konstantinos I., et al.
Publicado: (2023)

Ahnak promotes tumor metastasis through transforming growth factor-β-mediated epithelial-mesenchymal transition
por: Sohn, Mira, et al.
Publicado: (2018)

The Role of Next-Generation Probiotics in Obesity and Obesity-Associated Disorders: Current Knowledge and Future Perspectives
por: Vallianou, Natalia G., et al.
Publicado: (2023)

Laboratory Findings and Biomarkers in Long COVID: What Do We Know So Far? Insights into Epidemiology, Pathogenesis, Therapeutic Perspectives and Challenges
por: Tsilingiris, Dimitrios, et al.
Publicado: (2023)

Epithelial-mesenchymal transition in breast cancer progression and metastasis
por: Wang, Yifan, et al.
Publicado: (2011)

Contribution of epithelial-mesenchymal transitions to organogenesis and cancer metastasis
por: Campbell, Kyra
Publicado: (2018)

Epithelial-to-Mesenchymal Transition in Metastasis: Focus on Laryngeal Carcinoma
por: Goulioumis, Anastasios, et al.
Publicado: (2022)

Can a fibrotic liver afford epithelial-mesenchymal transition?
por: Munker, Stefan, et al.
Publicado: (2017)

Corepressor metastasis-associated protein 3 modulates epithelial-to-mesenchymal transition and metastasis
por: Du, Liang, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_s74euiik17vrhs6lt72isvdrra